Print

Print


----------
> From: Sharon & Jim LeBlanc <[log in to unmask]>
> To: [log in to unmask]
> Subject: Seventh Reference for Environmental Parkinsons - Pollutant
Botulism - Clostridium Botulinum
> Date: Tuesday, July 06, 1999 11:40 AM
>
> Map of Parkinsons Diseases
>
> Biochemical Pathways Map No. O10 P10 - Aerobic Respiraton of Mitochondria
>
> Complex I - NADH - FAD - Quinone
>                  NADPH OXIDASE - NADH (NADH supplements for Parkinsons)
> (CoQ10 supplements for Parkinsons)
>                  NADPH OXIDASE - RAC - RAC3-Clostridium Botulinum
>                  RAC3 - Bcr-breakpoint cluster - RARA - Retinoic Receptor
-
> Retinoid X receptor - TARGRETIN - ALRT drugs
>                  Bcr- Parkinsonian Birth Defects - Color Blindness &
> Olfactory caused by cRA N-nitrosodimethylamine
>                  NADPH OXIDASE - RASrelated - RAS3- ADP (adenosine
> diphosphate) ribosylation - CREB-CREB2
>                  NADPH OXIDASE - clostridium botulism -
CXX-COOH-Cytochrome
> b 558 - cytochrome c
>                  NDUFV2 Mutation - no NADH - Parkinsons Disease
>                  FAD - Rotenone - Mutation of FAD - Parkinsons Disease
>
> Complex II - Succinate Dehydrogenase - Part of Citrate Cycle or
> Tricarboxylic Cycle
>                   Succinyl CoA - cAMP or cyclic Adenosine Monophosphate
>                   cAMP - ethyl carbamate - dithioethylcarbamate - caspase
> inhibitor- enhanced MPTP- synthetic drug Parkinsons Disease
>                   cAMP- adenyl cyclase- Pertussis - prone to Parkinsons
> Disease in old age
>                   CREB - cis response element of cAMP (Retinoic)
>                   CREB - Proenkephalin (Enkephalin and D2 Dopamine
> Receptors) and TCL4 (Cutaneous lymphoma or Cancer)
>                   CREB - Targretin is for Nitrosodimethylurea induced
TCLC
> breast cancer
>                   CREB2 - CREB
>                   CREB2 - C/EBP - Myeloperoxidase Promoter - Lipid
> Peroxidation
>                   Increased Lipid Peroxidation - 4HNE mutation Parkinsons
> Disease
>                                                             - SOD1 and
SOD2
> Lewy Body Parkinsons Disease
>                                                             - ALPHA
> SYNUCLEIN - Park 1,2,3 Parkinsons Diseases (Increased Threonine causes
> increased lipids into the brain causing increased lipid peroxidation and
> Parkinsons Disease
>                                                             - APOE4 -
> Apolipoprotein Mutation - Parkinsons Disease
>                                                             - Pelizaeus
> Merzbacher - Parkinsons Disease
>                   CREB-CREB2- Retinoic Acid Binding Protein -CCAAT or
CUTL1
> or Caspase-1
>                   CCAAT-AAT-Elevated in Parkinsons- Mutation causes
> Alzheimers Disease
>                   AAT-Transglutaminase - Huntingtin-
N-Nitrosodimethylamine
> and Dimethylamine inhibition - Environmental Parkinsons
>                   CREB-CREB2-CRAB2- Nicotinic-acetylcholine receptors
Acra
> (Alpha chain) and Catalase (Cas-1)
>                   CYP 450 - Metabolizes Retinoic Acid -
> N-Nitrosodimethylamine - Mutation of CYP450- Parkinsons Disease
>                   CRAB2- Acetylcholine Receptor - Homogentisic Acid (
> Benzoquinone Acetic Acid )- Alkaptonuria Parkinsons Disease
>                                                                  -
> Homovanillic Acid L205- Parkinsons Disease
>
> Complex III - Rieske  Mutation - Parkinsons Disease
>                    Increased iron in blood - Parkinsons Disease
>                    Increased Manganese - SOD2 - Parkinsons Disease
>                    Cytochrome C - Human growth factor - Stem Cells - GDNF
-
> Glial Derived Growth Factor - RXR-RAR Orphan Receptors
>                    RXR Mutant Mice - Parkinsons Locomotion - Targretin
>
> Complex IV - Cytochrome C Oxidase - Iron - Metallic ions bond with
> N-Nitrosodimethylamine and Dimethylamine
>
> Complex V - nH - ATP - ADP - Nadph Oxidase - N-Nitrosodimethylamine -
> uncoupling protein in brown fat cells
>
> [log in to unmask]
>